SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-18-013662
Filing Date
2018-03-08
Accepted
2018-03-08 17:21:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tv488043_424b5.htm 424B5 321561
2 GRAPHIC lg_checkpoint-lr.jpg GRAPHIC 22219
  Complete submission text file 0001144204-18-013662.txt   353300
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221493 | Film No.: 18677479
SIC: 2834 Pharmaceutical Preparations